Facility Expansion to Double Cannabis Production | CannTrust

Cannabis is a booming global economy. CannTrust is growing to meet soaring demands by expanding their Niagara Perpetual harvest facility. CannTrust is doubling cannabis production from fifty to one hundred thousand kilograms by 2019. By doing this they are entering the Canadian recreational market.  They are demonstrating market leadership with innovations like BrewBudz and other cannabis infused beverages.

They are a federally regulated licensed producer. Who brings more than 40 years of pharmacy and healthcare experience to the Medical Cannabis industry. We apply this expertise to produce 100% pesticide free standardized Medical Cannabis for patients in need.

At CannTrustâ„¢ we committ to research and innovation, as well as contribute to the growing body of evidence-based research regarding the use and efficacy of cannabis. Our product development teams along with our exclusive pharma partner Apotex are diligently innovating and developing products. Health Canada has granted a Section 9 License to CannTrust under the Narcotic Control Regulations. This allows us to expand our product development and research to include pharmaceuticals in an effort to make it easier for patients to use Medical Cannabis today and in the future.

Our onsite laboratory with advanced technology and equipment for testing and research on the medical use of cannabis provides CannTrust with the ability to develop and rigorously test our products at any point.

For more information on CannTrust (TRST:TSX) please fill out the form below.

Request Investor Kit

Name*

Email*

*Required.